cvGe.com
About cvGe.com
Cardio Vascular Bio Therapeutics - CVBT is a biopharmaceutical company established to commercialize the breakthrough therapy developed by Dr. Thomas-Joseph Stegmann to treat coronary artery disease with a process known as angiogenesis. The treatment consists of injecting human growth factor near a blocked coronary artery which in turn, improves blood flow into the ischemic heart.
